Immunochemistry Analyzers - Medical Devices Pipeline Assessment, 2018

Publisher Name :
Date: 11-Jul-2018
No. of pages: 453

Immunochemistry Analyzers - Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, "Immunochemistry Analyzers - Medical Devices Pipeline Assessment, 2018" provides an overview of Immunochemistry Analyzers currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Immunochemistry Analyzers pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Immunochemistry Analyzers under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Immunochemistry Analyzers and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry.

Reasons to buy

The report enables you to -

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Immunochemistry Analyzers under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date.

Immunochemistry Analyzers - Medical Devices Pipeline Assessment, 2018

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 10
1.2 List of Figures 16
2 Introduction 17
2.1 Immunochemistry Analyzers Overview 17
3 Products under Development 18
3.1 Immunochemistry Analyzers - Pipeline Products by Stage of Development 18
3.2 Immunochemistry Analyzers - Pipeline Products by Segment 19
3.3 Immunochemistry Analyzers - Pipeline Products by Territory 20
3.4 Immunochemistry Analyzers - Pipeline Products by Regulatory Path 21
3.5 Immunochemistry Analyzers - Pipeline Products by Estimated Approval Date 22
3.6 Immunochemistry Analyzers - Ongoing Clinical Trials 23
4 Immunochemistry Analyzers - Pipeline Products under Development by Companies 24
4.1 Immunochemistry Analyzers Companies - Pipeline Products by Stage of Development 24
4.2 Immunochemistry Analyzers - Pipeline Products by Stage of Development 28
5 Immunochemistry Analyzers Companies and Product Overview 31
5.1 Abbott Diagnostics Company Overview 31
5.2 Acrongenomics Inc. (Inactive) Company Overview 32
5.3 AgPlus Diagnostics LTD Company Overview 33
5.4 Akers Biosciences Inc Company Overview 34
5.5 Akonni Biosystems Inc Company Overview 35
5.6 Alere Inc Company Overview 36
5.7 Analytical Diagnostic Solutions Inc Company Overview 37
5.8 ApoCell Inc Company Overview 38
5.9 Ativa Medical Inc Company Overview 39
5.10 Atonomics A/S Company Overview 40
5.11 Beckman Coulter Inc Company Overview 43
5.12 Binghamton University Company Overview 44
5.13 Bio-Alternative Medical Devices Ltd Company Overview 45
5.14 BioMedomics Inc Company Overview 46
5.15 bioMerieux SA Company Overview 47
5.16 Biopico Systems Inc Company Overview 48
5.17 Biosan Medical Ltd. Company Overview 49
5.18 BioSIMS Company Overview 50
5.19 Boditech Med Inc Company Overview 51
5.20 Boston University Company Overview 52
5.21 BreviTest Technologies LLC Company Overview 54
5.22 Canon USA Inc Company Overview 56
5.23 CardioGenics Inc Company Overview 57
5.24 Cepheid Company Overview 58
5.25 China Medical Technologies Inc (Inactive) Company Overview 61
5.26 ChipCare Corp Company Overview 62
5.27 City, University of London Company Overview 64
5.28 Clearbridge BioLoc Pte Ltd Company Overview 65
5.29 Co-Diagnostics HBDC, Inc. Company Overview 66
5.30 Corgenix Medical Corp Company Overview 67
5.31 Denator AB Company Overview 68
5.32 Diagnostics For All Inc Company Overview 69
5.33 DiaSorin SpA Company Overview 70
5.34 Dyamed Biotech Pte Ltd Company Overview 71
5.35 EKF Diagnostics Holdings Plc Company Overview 72
5.36 EMD Millipore Corp Company Overview 73
5.37 Enigma Diagnostics Ltd (Inactive) Company Overview 74
5.38 ExcitePCR Corp Company Overview 75
5.39 Exosome Diagnostics Inc Company Overview 76
5.40 Firalis SAS Company Overview 77
5.41 First Light Biosciences Inc Company Overview 78
5.42 Florida International University Company Overview 79
5.43 Fluxergy LLC Company Overview 80
5.44 Genera Biosystems Ltd Company Overview 81
5.45 Genevo Biosystems Pte Ltd Company Overview 82
5.46 Giner Inc Company Overview 83
5.47 GNA Biosolutions GmbH Company Overview 84
5.48 Great Basin Scientific Inc Company Overview 85
5.49 HeatFlow Technologies Inc Company Overview 86
5.50 Hologic Inc Company Overview 87
5.51 Indian Institute of Technology Chennai Company Overview 88
5.52 Johnson & Johnson Company Overview 89
5.53 LabNow Inc (Inactive) Company Overview 90
5.54 Lucerna Inc Company Overview 91
5.55 Magellan Diagnostics Inc Company Overview 92
5.56 Maxygen-mobile DNA tests Company Overview 93
5.57 mBio Diagnostics Inc Company Overview 94
5.58 McKesson Corp Company Overview 96
5.59 MedNostic Technologies, LLC Company Overview 97
5.60 Meridian Bioscience Inc Company Overview 98
5.61 MML Ltd Company Overview 102
5.62 Molecular Warehouse Ltd Company Overview 103
5.63 Nalia Systems Ltd Company Overview 104
5.64 NanoLab Inc Company Overview 105
5.65 Newcastle University Company Overview 107
5.66 Nikkiso Co Ltd Company Overview 109
5.67 Ohmx Corp Company Overview 110
5.68 OncoGenesis Company Overview 111
5.69 OncoTherapy Science Inc Company Overview 112
5.70 Ortho-Clinical Diagnostics Inc Company Overview 113
5.71 Pacific Nanoscience, Inc. Company Overview 114
5.72 Parallax Health Sciences Inc Company Overview 115
5.73 POC Medical Systems Inc. Company Overview 116
5.74 Polymedco CDP, LLC Company Overview 117
5.75 Protomex Life Sciences Company Overview 118
5.76 Qiagen NV Company Overview 119
5.77 Quanterix Corp Company Overview 120
5.78 Qvella Corporation Company Overview 121
5.79 Radisens Diagnostics Ltd Company Overview 122
5.80 Raman Diagnostics Ltd (Inactive) Company Overview 123
5.81 Rapid Diagnostek, Inc. Company Overview 124
5.82 Roche Diagnostics International Ltd Company Overview 125
5.83 Sebia SA Company Overview 126
5.84 SenGenix Inc Company Overview 129
5.85 SFC Fluidics LLC Company Overview 130
5.86 Singulex Inc Company Overview 131
5.87 Spectradyne LLC Company Overview 134
5.88 StemTek Therapeutics SL Company Overview 135
5.89 Tecan Group Ltd Company Overview 136
5.90 Techcomp (Holdings) Ltd Company Overview 137
5.91 The Palo Alto Research Center Company Overview 138
5.92 Thermal Gradient Inc Company Overview 139
5.93 Trinity Biotech Plc Company Overview 141
5.94 Two Pore Guys Inc Company Overview 142
5.95 Tyncbest Biotechnology Company Overview 143
5.96 University of California Berkeley Company Overview 144
5.97 University of Illinois at Urbana-Champaign Company Overview 147
5.98 University of Michigan Pediatric Device Consortium Company Overview 148
5.99 University of South Florida Company Overview 149
5.100 Virogenomics BioDevelopment Inc Company Overview 150
5.101 Wellstat Diagnostics LLC Company Overview 151
5.102 Xanthostat Diagnostics Inc Company Overview 152
6 Immunochemistry Analyzers- Recent Developments 153
6.1 Jun 28, 2018: McKesson Reaffirms Fiscal 2019 Guidance and Provides Preliminary Guidance for the First Quarter 153
6.2 Jun 27, 2018: BD, Heart to Heart International and the NAFC Announce 2018 Grantees for a Multi-Year Point of Care Testing Initiative to Improve Patient Outcomes 153
6.3 Jun 25, 2018: PositiveID Subsidiary Chief Science Officer Joins Cambridge Healthtech Institute's 26th Biodetection Technologies: Biothreat and Pathogen Detection 154
6.4 Jun 22, 2018: Johnson & Johnson Announces Retirement of Group Worldwide Chairman, Sandra E. Peterson 154
6.5 Jun 22, 2018: Johnson & Johnson Appoints Senior Leaders to Executive Committee 155
6.6 Jun 22, 2018: Bob Schruender, CEO Joins Sekisui Medical Board of Directors 156
6.7 Jun 22, 2018: Trovagene Announces Senior Management Change 156
6.8 Jun 21, 2018: Abbott Receives FDA Clearance for Afinion HbA1c Dx for Diagnosing Diabetes 157
6.9 Jun 20, 2018: PositiveID CEO Details New Distribution Agreement with Leading Non-Invasive Patient Monitoring Technology Company 157
6.10 Jun 20, 2018: Immunodiagnostic Systems: Final Results for year ended 31 March 2018 158
6.11 Jun 19, 2018: ALPCO to Feature New STELLUX Chemi Active GLP-1 (7-36) amide ELISA and Young Investigators Travel Grant Program at ADA's 78th Scientific Sessions 162
6.12 Jun 13, 2018: SQI Diagnostics Names Eric Zwisler As Board Director 162
6.13 Jun 12, 2018: Bioasis Technologies Dr. Mario Saltarelli, Dr. Jack Hoppin And Dr. Sue O Connor To Its Scientific Advisory Board 163
6.14 Jun 12, 2018: Change at the top of the Segment Advanced Therapies at Siemens Healthineers 164
6.15 Jun 11, 2018: InSphero Partners with ALPCO to Advance Diabetes Research 165
6.16 Jun 05, 2018: Johnson & Johnson Announces Progress Toward Health for Humanity Goals 165
6.17 Jun 01, 2018: BD Appoints John DeFord As Chief Technology Officer 166
6.18 Jun 01, 2018: ISBT Satellite Symposium Co-hosted by Ortho Clinical Diagnostics and Quotient Discusses Responding to the Challenges of Resource Constraints in Transfusion Diagnostics 167
7 Appendix 448
7.1 Methodology 448
7.2 About GlobalData 451
7.3 Contact Us 451
7.4 Disclaimer 451

1.1 List of Tables
Table 1: Immunochemistry Analyzers - Pipeline Products by Stage of Development 20
Table 2: Immunochemistry Analyzers - Pipeline Products by Segment 21
Table 3: Immunochemistry Analyzers - Pipeline Products by Territory 22
Table 4: Immunochemistry Analyzers - Pipeline Products by Regulatory Path 23
Table 5: Immunochemistry Analyzers - Pipeline Products by Estimated Approval Date 24
Table 6: Immunochemistry Analyzers - Ongoing Clinical Trials 25
Table 7: Immunochemistry Analyzers Companies - Pipeline Products by Stage of Development 26
Table 8: Immunochemistry Analyzers - Pipeline Products by Stage of Development 30
Table 9: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 33
Table 10: Alinity i System - Product Status 33
Table 11: Alinity i System - Product Description 33
Table 12: Acrongenomics Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 34
Table 13: BioLED Device - Diabetes Management - Product Status 34
Table 14: BioLED Device - Diabetes Management - Product Description 34
Table 15: AgPlus Diagnostics LTD Pipeline Products & Ongoing Clinical Trials Overview 35
Table 16: AgPlus Diagnostic System - Product Status 35
Table 17: AgPlus Diagnostic System - Product Description 35
Table 18: Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 36
Table 19: minDNAnalyzer - Product Status 36
Table 20: minDNAnalyzer - Product Description 36
Table 21: Akonni Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 37
Table 22: TruDx 2000 Platform - Product Status 37
Table 23: TruDx 2000 Platform - Product Description 37
Table 24: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 38
Table 25: Clondiag HIV Molecular Device - Product Status 38
Table 26: Clondiag HIV Molecular Device - Product Description 38
Table 27: Analytical Diagnostic Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 39
Table 28: POC Device - Malaria - Product Status 39
Table 29: POC Device - Malaria - Product Description 39
Table 30: ApoCell Inc Pipeline Products & Ongoing Clinical Trials Overview 40
Table 31: ApoStream System - Product Status 40
Table 32: ApoStream System - Product Description 40
Table 33: Ativa Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 41
Table 34: Ativa Micro-Lab System - Product Status 41
Table 35: Ativa Micro-Lab System - Product Description 41
Table 36: Atonomics A/S Pipeline Products & Ongoing Clinical Trials Overview 42
Table 37: Atolyzer Consumer Device - Product Status 42
Table 38: Atolyzer Consumer Device - Product Description 42
Table 39: Atolyzer Gene - Product Status 43
Table 40: Atolyzer Gene - Product Description 43
Table 41: Atolyzer PoC - Product Status 43
Table 42: Atolyzer PoC - Product Description 44
Table 43: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 45
Table 44: UniCel DxN - Product Status 45
Table 45: UniCel DxN - Product Description 45
Table 46: Binghamton University Pipeline Products & Ongoing Clinical Trials Overview 46
Table 47: U-PAC - Product Status 46
Table 48: U-PAC - Product Description 46
Table 49: Bio-Alternative Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview 47
Table 50: Magnetic Immunoassay Detection System - Product Status 47
Table 51: Magnetic Immunoassay Detection System - Product Description 47
Table 52: BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview 48
Table 53: TR-LFIA Diagnostic Platform - Product Status 48
Table 54: TR-LFIA Diagnostic Platform - Product Description 48
Table 55: bioMerieux SA Pipeline Products & Ongoing Clinical Trials Overview 49
Table 56: Magnotech System - Product Status 49
Table 57: Magnotech System - Product Description 49
Table 58: Biopico Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 50
Table 59: MONITOR System - Product Status 50
Table 60: MONITOR System - Product Description 50
Table 61: Biosan Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 51
Table 62: DNA And Protein Array Scanner System - Product Status 51
Table 63: DNA And Protein Array Scanner System - Product Description 51
Table 64: BioSIMS Pipeline Products & Ongoing Clinical Trials Overview 52
Table 65: DigiPLEX Analyzer - Product Status 52
Table 66: DigiPLEX Analyzer - Product Description 52
Table 67: Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview 53
Table 68: AFIAS6 - Product Status 53
Table 69: AFIAS6 - Product Description 53
Table 70: Boston University Pipeline Products & Ongoing Clinical Trials Overview 54
Table 71: Lab-On-A-Chip - Thyroid Cancer - Product Status 54
Table 72: Lab-On-A-Chip - Thyroid Cancer - Product Description 54
Table 73: Point-Of-Care Device - Allergen-Specific IgE - Product Status 55
Table 74: Point-Of-Care Device - Allergen-Specific IgE - Product Description 55
Table 75: BreviTest Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 56
Table 76: BreviTest Portable Analyzer - Product Status 56
Table 77: BreviTest Portable Analyzer - Product Description 56
Table 78: BreviTest Robotic Analyzer - Product Status 57
Table 79: BreviTest Robotic Analyzer - Product Description 57
Table 80: Canon USA Inc Pipeline Products & Ongoing Clinical Trials Overview 58
Table 81: Automated Diagnostic System - Infectious Disease - Product Status 58
Table 82: Automated Diagnostic System - Infectious Disease - Product Description 58
Table 83: CardioGenics Inc Pipeline Products & Ongoing Clinical Trials Overview 59
Table 84: QL Care Analyzer - Product Status 59
Table 85: QL Care Analyzer - Product Description 59
Table 86: Cepheid Pipeline Products & Ongoing Clinical Trials Overview 60
Table 87: GeneXpert Omni - Product Status 60
Table 88: GeneXpert Omni - Product Description 60
Table 89: Cepheid - Ongoing Clinical Trials Overview 61
Table 90: GeneXpert Omni - Xpert Omni Performance Evaluation for Linkage to Tuberculosis Care: The XPEL TB Trial 62
Table 91: China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 63
Table 92: SPR Analyzer - Product Status 63
Table 93: SPR Analyzer - Product Description 63
Table 94: ChipCare Corp Pipeline Products & Ongoing Clinical Trials Overview 64
Table 95: Handheld Tester - Malaria - Product Status 64
Table 96: Handheld Tester - Malaria - Product Description 64
Table 97: Polyvalent Analyzer (PAx) - Product Status 64
Table 98: Polyvalent Analyzer (PAx) - Product Description 65
Table 99: City, University of London Pipeline Products & Ongoing Clinical Trials Overview 66
Table 100: POC Device - Mood Disorders - Product Status 66
Table 101: POC Device - Mood Disorders - Product Description 66
Table 102: Clearbridge BioLoc Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 67
Table 103: AssayQuest - Product Status 67
Table 104: AssayQuest - Product Description 67
Table 105: Co-Diagnostics HBDC, Inc. Pipeline Products & Ongoing Clinical Trials Overview 68
Table 106: LightPCR - Product Status 68
Table 107: LightPCR - Product Description 68
Table 108: Corgenix Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 69
Table 109: ELISA Microplate Reader - Product Status 69

1.2 List of Figures
Figure 1: Immunochemistry Analyzers - Pipeline Products by Stage of Development 20
Figure 2: Immunochemistry Analyzers - Pipeline Products by Segment 21
Figure 3: Immunochemistry Analyzers - Pipeline Products by Territory 22
Figure 4: Immunochemistry Analyzers - Pipeline Products by Regulatory Path 23
Figure 5: Immunochemistry Analyzers - Pipeline Products by Estimated Approval Date 24
Figure 6: Immunochemistry Analyzers - Ongoing Clinical Trials 25
  • Global Prenatal Genetic Testing Market Analysis 2015-2019 and Forecast 2020-2025
    Published: 11-Feb-2020        Price: US 2980 Onwards        Pages: 89
    Snapshot The global Prenatal Genetic Testing market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Prenatal Genetic Testing by product, region and application, in addition, this report introduces market competition situation among the vendor......
  • 2020 Tricyclic Antidepressants Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations
    Published: 10-Feb-2020        Price: US 1500 Onwards        Pages: 0
    This new report from LeadingMarketResearch.com provides analysis of Tricyclic Antidepressants testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment. Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing - Hospitals - Commerci......
  • 2020 Propoxyphene Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations
    Published: 10-Feb-2020        Price: US 1500 Onwards        Pages: 0
    This new report from LeadingMarketResearch.com provides analysis of Propoxyphene testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment. Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing - Hospitals - Commercial/Private La......
  • 2020 Phencyclidine Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations
    Published: 10-Feb-2020        Price: US 1500 Onwards        Pages: 0
    This new report from LeadingMarketResearch.com provides analysis of Phencyclidine testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment. Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing - Hospitals - Commercial/Private L......
  • 2020 Opiates Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations
    Published: 10-Feb-2020        Price: US 1500 Onwards        Pages: 0
    This new report from LeadingMarketResearch.com provides analysis of Opiates testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment. Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing - Hospitals - Commercial/Private Laborat......
  • 2020 Methaqualone Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations
    Published: 10-Feb-2020        Price: US 1500 Onwards        Pages: 0
    This new report from LeadingMarketResearch.com provides analysis of Methaqualone testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment. Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing - Hospitals - Commercial/Private La......
  • 2020 Methadone Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations
    Published: 10-Feb-2020        Price: US 1500 Onwards        Pages: 0
    This new report from LeadingMarketResearch.com provides analysis of Methadone testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment. Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing - Hospitals - Commercial/Private Labor......
  • 2020 LSD Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations
    Published: 10-Feb-2020        Price: US 1500 Onwards        Pages: 0
    This new report from LeadingMarketResearch.com provides analysis of LSD testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment. Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing - Hospitals - Commercial/Private Laboratorie......
  • 2020 Cocaine Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations
    Published: 10-Feb-2020        Price: US 1500 Onwards        Pages: 0
    This new report from LeadingMarketResearch.com provides analysis of Cocaine testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment. Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing - Hospitals - Commercial/Private Laborat......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs